Amphastar Pharmaceuticals price to sales ratio AMPH
Market value divided by revenue over the last twelve months, since 2015.
- Today, Nov 2, 2026
- 1.6×
- 10-year median
- 2.9×
- Against its 10-year history
- 9th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 1.0× to 5.8×
- Peer median
- 1.8×
Amphastar Pharmaceuticals' price to sales ratio is 1.6× as of Nov 2, 2026.
That is below its ten-year median of 2.9×, lower than on 91% of days in the last ten years.
Over that time it ranged from 1.0× in May 2026 to 5.8× in Aug 2023.
The median for 10 large drugmakers of a similar size is 1.8×.
Price to sales ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.6× | 1.0× | 1.9× |
| 2025 | 1.7× | 1.3× | 2.4× |
| 2024 | 2.5× | 2.5× | 5.0× |
| 2023 | 4.9× | 2.9× | 5.8× |
| 2022 | 2.8× | 2.8× | 4.6× |
| 2021 | 2.7× | 2.2× | 2.8× |
| 2020 | 2.8× | 1.8× | 3.1× |
| 2019 | 2.7× | 2.5× | 4.4× |
| 2018 | 3.5× | 2.9× | 3.8× |
| 2017 | 3.6× | 2.5× | 3.7× |
| 2016 | 3.2× | 2.1× | 3.6× |
| 2015 | 2.8× | 2.3× | 3.6× |
Against its peers
Companies in Drug Manufacturers - General nearest Amphastar Pharmaceuticals' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| AMPHAmphastar Pharmaceuticals | 1.6× |
| OMEROmeros | n/m |
| ANABAnaptysbio | n/m |
| PCRXPacira BioSciences | 1.9× |
| PAHCPhibro Animal Health | 1.0× |
| ANIPANI Pharmaceuticals | 1.7× |
| ABUSArbutus Biopharma | 4.4× |
| COLLCollegium Pharmaceutical | 1.0× |
| ZVRAZevra Therapeutics | 4.4× |
| HRMYHarmony Biosciences | 2.3× |
| IRWDIronwood Pharmaceuticals | 1.5× |
| Peer median | 1.8× |
Where Amphastar Pharmaceuticals ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Amphastar Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.